What is the Precision Medicine Alliance?
The Precision Medicine Alliance is a joint venture between Catholic Health Initiatives and Dignity Health, two of the nation’s largest health systems. The Alliance is the most expansive community-based precision-medicine program in the nation, offering patients faster and more accurate treatments based on their individual genetic profiles.
Why is this program important?
When patients are diagnosed, they are immediately faced with questions about the best treatment options. Use of genetic information is an emerging diagnostic and treatment option for a number of diagnoses because it helps identify which treatments would be most effective for each patient, based on their unique genetic profiles. But, these treatment programs are often difficult to access and are generally not offered in most community hospitals.
The Precision Medicine Alliance intends to change that.
How do we make it happen?
With an initial focus on oncology, we will offer patients advanced diagnostic tumor profiling and targeted therapies, with plans to expand to other areas where knowing a patient’s genetic profile leads to better care and outcomes.
Our oncology initiative will enable physicians to request guidance from experts throughout the networks, access targeted therapies with key support programs, and enroll patients in molecularly matched clinical trials.
Dedicated to building sustainable genomics-guided healthcare solutions that enable a higher level of care in our communities, we are focused on:
Ultimately our platform will be available at more than 150 hospitals and care centers across the U.S., serving a potential population of approximately 12 million patients annually.